₹74 Crore Pharma Fraud Case: Three Accused Seek Anticipatory Bail Amid EOW Investigation
In a significant development within the pharmaceutical sector, three individuals linked to Zorvia Healthcare have sought anticipatory bail in connection with a ₹74 crore fraud investigation led by the Economic Offences Wing (EOW) of the Mumbai Police. This case has escalated into a complex legal battle involving allegations of corporate misconduct, including breach of non-compete agreements and the misappropriation of sensitive business data.
Contractual Breaches and Preemptive Bail Petitions
The ongoing investigation centers around Emcure Pharmaceuticals and its subsidiary, Zuventus Healthcare, alongside rival Zorvia Healthcare. The allegations include violations of non-compete agreements, employee poaching, and the theft of confidential business information. The anticipatory bail applications were submitted by Chandrakant Vittal Shetty, Anand Vittal Shetty, and Reji Verghese, all associated with Zorvia Healthcare.
The prosecution’s case stems from a complaint filed by Emcure Pharmaceuticals’ Chief Financial Officer, which asserts that former stakeholders of Zuventus Healthcare engaged in unfair competitive practices. The complaint alleges that a competing entity was established in November 2025, leading to a mass exodus of employees and the unauthorized transfer of sensitive information.
During court proceedings, the seriousness of the allegations was underscored, with the FIR indicating that the cheating charges exceed ₹74 crore. The court acknowledged submissions from both parties, including claims that the dispute is primarily commercial and already under consideration in parallel civil proceedings. The matter has been scheduled for further hearing on June 2, following the issuance of a notice to the prosecution.
Mass Employee Exits and Operational Disruptions
According to the complaint, approximately 950 employees from various departments, including HR, IT, legal, marketing, and sales, allegedly resigned between October and December 2025 to join the rival firm. This mass resignation is claimed to have severely disrupted operations and affected business continuity across multiple divisions of the pharmaceutical company.
Investigators have alleged that confidential commercial data, including product details, export records, and research materials, were transferred to personal email accounts. A technical audit has reportedly revealed that intellectual property and research and development data valued at over ₹100 crore were either deleted or misused, forming a crucial aspect of the ongoing investigation.
The FIR also states that Zuventus Healthcare experienced a reported sales decline of ₹74.96 crore from October 2025 to March 2026, with monthly revenue losses estimated between ₹7 crore and ₹10 crore. These financial setbacks are attributed to the alleged employee attrition and subsequent operational disruptions following the establishment of the competing company.
Shareholders’ Agreements and Private Severance Frameworks
At the core of this dispute lies a shareholders’ agreement signed in 2002, which purportedly includes stringent non-compete and non-solicitation clauses. The complainant argues that these clauses were violated, resulting in unfair competition and the misuse of sensitive corporate information.
The accused have contended that the matter is fundamentally a commercial dispute and that the criminal proceedings are being exploited to exert undue pressure. Their legal representatives have highlighted that related civil proceedings are already pending in other judicial forums.
The court has noted that the gravity of the allegations necessitates a thorough examination before granting any interim protection. The prosecution has opposed the anticipatory bail, asserting that custodial interrogation may be essential to fully uncover the extent of the alleged data transfer and its financial repercussions.
Corporate Governance Friction and Custodial Demands
As the EOW continues its investigation, officials are scrutinizing digital records, email communications, and financial transactions associated with the accused entities. They are also assessing whether sensitive intellectual property was intentionally diverted to competing business platforms.
Legal experts indicate that this case exemplifies the growing friction between corporate governance frameworks and criminal law enforcement in disputes involving intellectual property and employee mobility. The outcome of the bail hearing is poised to influence the next phase of the investigation, as the court balances the competing claims of commercial dispute against alleged criminal misconduct.
For more detailed coverage on this evolving situation, visit the420.in.
Keep reading for the latest cybersecurity developments, threat intelligence and breaking updates from across the Middle East.
